| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) | 
|---|
| 10/17/2013 | US20130274188 Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same | 
| 10/17/2013 | US20130273659 Nanoparticles of cerium and amino acids | 
| 10/17/2013 | US20130273284 Biodegradable multi-block co-polymers | 
| 10/17/2013 | US20130273167 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same | 
| 10/17/2013 | US20130273159 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments | 
| 10/17/2013 | US20130273145 Compositions, the preparation and use thereof | 
| 10/17/2013 | US20130273140 Controlled Release Formulations | 
| 10/17/2013 | US20130273122 Immobilised Biological Entities | 
| 10/17/2013 | US20130273115 Injectable filler | 
| 10/17/2013 | US20130273080 Sialoadhesin-related compositions and methods | 
| 10/17/2013 | US20130273068 Antibodies | 
| 10/17/2013 | US20130273047 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia | 
| 10/17/2013 | US20130273044 Compositions and Methods for Diagnosing and Treating Cancer | 
| 10/17/2013 | US20130273042 Treatment of multiple sclerosis | 
| 10/17/2013 | US20130273018 Recombinant human cln2 protein and methods of its production and use | 
| 10/17/2013 | US20130273000 Methods for treating viral infection using il-28 and il-29 | 
| 10/17/2013 | US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof | 
| 10/17/2013 | US20130272994 Non-Linear Multiblock Copolymer-Drug Conjugates for the Delivery of Active Agents | 
| 10/17/2013 | US20130272993 Co-polymer conjugates | 
| 10/17/2013 | US20130272992 Ion binding polymers and uses thereof | 
| 10/17/2013 | US20130272991 Ion binding polymers and uses thereof | 
| 10/17/2013 | US20130272990 Ion binding polymers and uses thereof | 
| 10/17/2013 | US20130272976 Water resistant compositions containing lactone compound and a hydroxy compound | 
| 10/17/2013 | US20130272975 Water resistant compositions containing a lactone compound and an amine compound chosen from amino alcohol compounds and alkoxylated amine compounds | 
| 10/17/2013 | US20130272964 Molecules with extended half-lives, compositions and uses thereof | 
| 10/17/2013 | CA2809473A1 Stabilized ketorolac compositions | 
| 10/16/2013 | EP2650312A2 Hyaluronic acid-protein conjugate and method for preparing same | 
| 10/16/2013 | EP2650309A1 Conjugate of folate and antibody, preparation method and use thereof | 
| 10/16/2013 | EP2650021A1 Medical device for controlled release of drug | 
| 10/16/2013 | EP2650019A1 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch | 
| 10/16/2013 | EP2650018A2 Antibody-LIGHT fusion products for cancer therapeutics | 
| 10/16/2013 | EP2649993A1 Stabilizer of acetaminophen | 
| 10/16/2013 | EP2649990A1 Compositions with reduced dimer formation | 
| 10/16/2013 | EP2649988A1 Sustained release of antiinfective aminoglycosides | 
| 10/16/2013 | EP2649132A2 Melt-blended protein composition | 
| 10/16/2013 | EP2649035A1 A complex of garcinol, cyclodextrin and method thereof | 
| 10/16/2013 | EP2648764A1 Multifunctional nanoparticles | 
| 10/16/2013 | EP2648760A2 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity | 
| 10/16/2013 | EP2648759A2 Targeting kidney mesangium with nanoparticles of defined diameter | 
| 10/16/2013 | EP2648758A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels | 
| 10/16/2013 | EP2648757A1 Pyrrolo[2,1-c][1,4]benzodiazepine linked imidazo[1,5-a]pyridine conjugates as potential antitumour agents and process for the preparation thereof | 
| 10/16/2013 | EP2648756A2 Targeting kidney mesangium with nanoparticles of defined diameter | 
| 10/16/2013 | EP2648755A1 A stable ready-to-use cetrorelix injection | 
| 10/16/2013 | EP2648753A2 Dosage and administration of bispecific scfv conjugates | 
| 10/16/2013 | EP2648751A2 Dimeric molecular complexes with free cysteine residues and conjugates thereof | 
| 10/16/2013 | EP2648746A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof | 
| 10/16/2013 | EP2648722A1 Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis | 
| 10/16/2013 | EP2648718A2 Implantable devices coated with insulin-mimetic agent composites and methods thereof | 
| 10/16/2013 | EP2648701A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs | 
| 10/16/2013 | CN1968714B Lipids, lipid complexes and use thereof | 
| 10/16/2013 | CN103354749A Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof | 
| 10/16/2013 | CN103349785A Traditional Chinese medicine volatile oil complex and preparation method thereof | 
| 10/16/2013 | CN103349784A Microsphere particle hydrogel medicine carrier for injection, and preparation method and application thereof | 
| 10/16/2013 | CN103349783A Nano photosensitive drug taking amphiphilic polysaccharide-folic acid conjugate as carrier and preparation method thereof | 
| 10/16/2013 | CN103349782A Preparation technology of chicken Eimeria tenella egg yolk antibody targeted sustained release preparation | 
| 10/16/2013 | CN103349780A Conjugation of streptococcal capsular saccharides | 
| 10/16/2013 | CN103349776A Edaravone injection solution and preparation method thereof | 
| 10/16/2013 | CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof | 
| 10/16/2013 | CN103349710A Compound tilmicosin clathrate complex and preparation method thereof | 
| 10/16/2013 | CN103349671A Resveratrol and spirulina composition and preparations and preparation method thereof | 
| 10/16/2013 | CN103349666A Pharmaceutical composition injection of compound liposoluble vitamin and preparation method thereof | 
| 10/16/2013 | CN103349659A Liquid compositions and application | 
| 10/16/2013 | CN103349657A Risperidone film-shaped preparation | 
| 10/16/2013 | CN103349656A Valsartan capsule and preparation method thereof | 
| 10/16/2013 | CN103349655A Tamoxifen citrate enteric capsules | 
| 10/16/2013 | CN103349654A Cefuroxime axetil pharmaceutical composition | 
| 10/16/2013 | CN103349651A Nifedipine sustained release tablet and preparation method thereof | 
| 10/16/2013 | CN103349650A Tamoxifen citrate sustained-release tablets | 
| 10/16/2013 | CN103349649A Tamoxifen citrate dispersible tablets | 
| 10/16/2013 | CN103349648A Tamoxifen citrate enteric-coated tablets | 
| 10/16/2013 | CN103349647A Tamoxifen citrate sustained-release granules | 
| 10/16/2013 | CN103349644A Lansoprazole complex micelle medicine composition for injection and preparation method thereof | 
| 10/16/2013 | CN103349643A Transdermal pharmaceutical preparations | 
| 10/16/2013 | CN103349285A Rganogel compositions and processes for producing | 
| 10/16/2013 | CN102973531B Levetiracetam medicine composition and preparation method thereof | 
| 10/16/2013 | CN102973516B Method for preparing monensin premix | 
| 10/16/2013 | CN102935119B Method for preparing ointment for treating lumbar disc herniation | 
| 10/16/2013 | CN102850710B Framework material for medical plaster and preparation method thereof | 
| 10/16/2013 | CN102755290B Medicine composition containing ibuprofen | 
| 10/16/2013 | CN102727886B Preparation method of immunostimulatory injection for livestock | 
| 10/16/2013 | CN102716092B Formula of aureomycin hydrochloride premix granule and granulating process | 
| 10/16/2013 | CN102716074B Bimatoprost eye drops and preparation method thereof | 
| 10/16/2013 | CN102652735B Porous silica nano particle loaded with medicaments with slight solubility and preparation method and application of particle | 
| 10/16/2013 | CN102626519B Prostatic cancer targeted multifunctional carbon nanotube / polyethylenimine drug delivery carrier, and preparation method and application thereof | 
| 10/16/2013 | CN102614155B Mixed litholytic agent for dissolving cholesterol stone | 
| 10/16/2013 | CN102614108B Cubic water quality liquid crystal gel transdermic absorption preparation containing oxybutynin chloride and preparing method thereof | 
| 10/16/2013 | CN102579579B Medicine composition for anaesthetic pain relief after crissum operation | 
| 10/16/2013 | CN102579409B Donepezil transdermal patch | 
| 10/16/2013 | CN102552623B Chinese medicine for nourishing yin, tonifying kidney, producing sperm and filling marrow and preparation method thereof | 
| 10/16/2013 | CN102552154B Albumin nanoparticle preparation for anthracycline antitumor antibiotic oleic acid compound | 
| 10/16/2013 | CN102516739B Multiple sensitive hydrogel material and preparation method thereof | 
| 10/16/2013 | CN102470121B Pharmaceutical compositions comprising dronedarone | 
| 10/16/2013 | CN102451471B Polyethyleneglycol-staphylokinase conjugate as well as preparing method and application thereof | 
| 10/16/2013 | CN102429986B Traditional Chinese ointment for treating burn and scald and preparation method thereof | 
| 10/16/2013 | CN102365077B Composition for oral cavity | 
| 10/16/2013 | CN102344371B Temperature-sensing amphiphilic polyether dendrons and their preparation method and use | 
| 10/16/2013 | CN102309765B Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same | 
| 10/16/2013 | CN102307579B Pharmaceutical composition for oral administration | 
| 10/16/2013 | CN102276727B IL-17RC-hFc fusion protein and application thereof | 
| 10/16/2013 | CN102210866B Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect |